Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Eargo, Inc. (EAR)

11.735   -0.235 (-1.96%) 02-03 15:51
Open: 11.82 Pre. Close: 11.97
High: 12.4499 Low: 11.68
Volume: 43,664 Market Cap: 243(M)

Technical analysis

as of: 2023-02-03 3:16:46 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 16.58     One year: 19.62
Support: Support1: 10    Support2: 8.31
Resistance: Resistance1: 14.2    Resistance2: 16.79
Pivot: 11.4
Moving Average: MA(5): 11.34     MA(20): 11.56
MA(100): 14.61     MA(250): 36.23
MACD: MACD(12,26): -0.2     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 26     %D(3): 20.8
RSI: RSI(14): 50.9
52-week: High: 116.8  Low: 0.8
Average Vol(K): 3-Month: 98 (K)  10-Days: 119 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ EAR ] has closed below upper band by 41.0%. Bollinger Bands are 44.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 73 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.47 - 12.52 12.52 - 12.57
Low: 11.68 - 11.73 11.73 - 11.78
Close: 11.89 - 11.97 11.97 - 12.07

Company Description

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Headline News

Fri, 03 Feb 2023
Healthy Tahoe: A guide to pediatric ear infections - Tahoe Daily Tribune

Fri, 03 Feb 2023
Eardrum perforation during attempt to dislodge bead from girl's ear leads to €250000 settlement - The Irish Times

Fri, 03 Feb 2023
Girl settles hearing loss case over ear procedure -

Fri, 03 Feb 2023
Influence of pneumatization on morphology of temporal bone-related vasculatures and their morphometric relationship ... -

Fri, 03 Feb 2023
Girl who suffered perforated eardrum after attempt to remove bead settles for €250k - Irish Examiner

Thu, 02 Feb 2023
Mayo Clinic Q and A: Understanding ear infections - Times-West Virginian

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 21 (M)
Shares Float 0 (M)
% Held by Insiders 82.5 (%)
% Held by Institutions 3.4 (%)
Shares Short 223 (K)
Shares Short P.Month 265 (K)

Stock Financials

EPS -4.47
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -18.44
Profit Margin (%) 0
Operating Margin (%) -387.1
Return on Assets (ttm) -52.5
Return on Equity (ttm) -480.7
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0.2
Sales Per Share 1.65
EBITDA (p.s.) -6.34
Qtrly Earnings Growth 0
Operating Cash Flow -142 (M)
Levered Free Cash Flow -99 (M)

Stock Valuations

PE Ratio -2.64
PEG Ratio 0
Price to Book value -0.64
Price to Sales 7.08
Price to Cash Flow -1.72

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.